Damora Therapeutics DMRA
NASDAQ DMRA
$21.09 -0.62 (-2.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Damora Therapeutics (DMRA) Return on Sales [ROS] (2021 - 2026)

Updated

Analysis

Damora Therapeutics (DMRA) Return on Sales [ROS] (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Damora Therapeutics 1.30 Bn -36.66 Mn - -862.13%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -862.13%
Mar 31, 2026 -1,003.62%
Dec 31, 2025 -20,149.45%
Sep 30, 2025 -7,514.29%
Jun 30, 2025 -6,842.00%
Mar 31, 2025 -3,512.16%
Dec 31, 2024 -3,114.91%
Sep 30, 2024 -2,630.14%
Jun 30, 2024 -2,618.31%
Mar 31, 2024 -2,233.85%
Dec 31, 2023 -1,962.06%
Sep 30, 2023 -1,814.59%
Jun 30, 2023 -2,524.66%
Mar 31, 2023 -3,108.76%
Dec 31, 2022 -4,762.32%
Sep 30, 2022 -6,163.80%
Jun 30, 2022 -19,908.14%
Mar 31, 2022 -27,768.85%
Dec 31, 2021 -44,893.33%
Sep 30, 2021 -36,968.57%
API Access

Damora Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=DMRA&period=max&api_key=YOUR_API_KEY